BeStock  

Amylyx Pharmaceuticals AMLX

US equityMarket cap rank #2350Drug Manufacturers - Specialty & Generic
$26.02 −$0.18 (-0.69%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $25.55 -1.81%
Open$25.64
Prev close$26.20
Day range$25.52 – $26.40
Volume1.14M
Market cap$3.35B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±7.9%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+21.1%
Worst reaction-31.9%

Stock move on the day after each report

+21.1%2023/Q4-2.1%2024/Q1-4.3%2024/Q2+5.1%2024/Q3+0.3%2024/Q4-6.0%2025/Q1-4.3%2025/Q2-5.9%2025/Q3-7.8%2025/Q4-5.4%2026/Q1+10.7%2026/Q2-6.1%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026Pre Market±10.4%-6.05%Within range
2026/Q26 Aug 2026Pre Market±29.3%+10.71%Within range
2026/Q17 May 2026Pre Market±9.7%-5.35%Within range
2025/Q43 Mar 2026Pre Market±19.3%-7.78%Within range
2025/Q36 Nov 2025Pre Market±18.2%-5.89%Within range
2025/Q27 Aug 2025Pre Market±18.8%-4.27%Within range
2025/Q18 May 2025Pre Market±26.6%-5.95%Within range
2024/Q44 Mar 2025Pre Market±21.7%+0.33%Within range
2024/Q37 Nov 2024Pre Market±17.3%+5.14%Within range
2024/Q28 Aug 2024Pre Market±24.2%-4.26%Within range
2024/Q19 May 2024Pre Market±15.0%-2.07%Within range
2023/Q422 Feb 2024Pre Market±24.5%+21.10%Within range
2023/Q39 Nov 2023Pre Market±13.9%-31.89%Bigger than priced
2023/Q210 Aug 2023After Market±17.8%+2.03%Within range
2023/Q111 May 2023After Market±17.5%-3.99%Within range
2022/Q413 Mar 2023After Market±21.0%+9.40%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$0.00
Operating profit-$49.66M-37.8% YoY
Net profit-$45.49M-32.3% YoY
Diluted EPS-$0.38-2.7% YoY
Free cash flow-$33.70M-10.9% YoY
Operating cash flow-$33.67M

Revenue, last 8 quarters

$-665.0KDec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26$0.0Sep '26

Net profit, last 8 quarters

$-37.5MDec '24$-35.9MMar '25$-41.4MJun '25$-34.4MSep '25$-33.0MDec '25$-41.3MMar '26$-43.4MJun '26$-45.5MSep '26

Profitability & balance sheet

Return on equity-30.1%
Return on assets-28.4%
Return on invested capital-32.0%
Current ratio26.81
Liabilities / assets4.2%
Cash & investments$768.13M
Total debt$4.01M
Net cash (debt)$764.12M

Discussion

No comments yet — be the first to weigh in on AMLX.

Sign in to join the discussion.

Scroll to Top